Patents by Inventor Xuan Guo

Xuan Guo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9635549
    Abstract: A host processing apparatus (100) and a user removable memory (40) are disclosed. The host processing apparatus (100) and the user removable memory (40) are, in use, connected to one another by respective connectors. The user removable memory (40) is provided in the form of a secure digital (SD) memory card with an expanded subscriber identity module (SIM) function. The host processing apparatus (100) is configured to convert SIM-related request signals to file access signals which identify a location or locations on the user removable memory (40) and one or more file access functions. The file access signals are transferred to the user removable memory (40) via the connectors.
    Type: Grant
    Filed: September 1, 2011
    Date of Patent: April 25, 2017
    Assignee: NOKIA TECHNOLOGIES OY
    Inventors: Canfeng Chen, Changjiang Zhang, Jianying Wen, Xuan Guo, Xin Zhang
  • Publication number: 20170022255
    Abstract: The present invention encompasses BTV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing BTV antigens. The invention also encompasses recombinant vectors encoding and expressing BTV antigens, epitopes or immunogens which can be used to protect animals, such as ovines, bovines, or caprines, against BTV.
    Type: Application
    Filed: April 14, 2016
    Publication date: January 26, 2017
    Applicant: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Xuan Guo, Kevin Cox
  • Patent number: 9345759
    Abstract: The present invention encompasses BTV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing BTV antigens. The invention also encompasses recombinant vectors encoding and expressing BTV antigens, epitopes or immunogens which can be used to protect animals, such as ovines, bovines, or caprines, against BTV.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: May 24, 2016
    Assignee: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Xuan Guo, Kevin Cox
  • Publication number: 20160030635
    Abstract: Provided herein are methods of producing extracellular matrix (ECM) that are superior to previously-described methods. Extracellular matrix (ECM) comprises protein that forms many structures in the body including tendons, ligaments, and sheets that support skin and internal organs. There remains a need in the art for ECM compositions that have improved cell attachment characteristics and methods of making such ECM compositions.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 4, 2016
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Mohit B. Bhatia, Aleksandr Kaplunovsky, Xuan Guo
  • Patent number: 9012197
    Abstract: The present invention is directed to recombinant microalgal cells and their use in production of heterologous hemagglutinin-neuraminidase (HN) polypeptides, as well as compositions and uses thereof.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: April 21, 2015
    Assignees: Merial, Inc., Sanofi Vaccine Technologies, S.A.S.
    Inventors: Anne-Cécile V. Bayne, James Casey Lippmeier, Kirk Emil Apt, Xuan Guo, Joyce A. Pritchard
  • Publication number: 20140255451
    Abstract: The present invention relates to an oxygen-sensitive macrocyclic triene lactone that is protected by addition of an appropriate amount of an antioxidant stabilizer during fabrication of an implantable medical device comprising the macrocyclic triene lactone, wherein the amount of the antioxidant stabilizer has been reduced to a minimal, preferably, non-detect, level in the final packaged product.
    Type: Application
    Filed: March 7, 2013
    Publication date: September 11, 2014
    Applicant: ABBOTT CARDIOVASCULAR SYSTEMS INC.
    Inventors: Stephen D. Pacetti, Sherry Xuan Guo
  • Publication number: 20140213321
    Abstract: A host processing apparatus (100) and a user removable memory (40) are disclosed. The host processing apparatus (100) and the user removable memory (40) are, in use, connected to one another by respective connectors. The user removable memory (40) is provided in the form of a secure digital (SD) memory card with an expanded subscriber identity module (SIM) function. The host processing apparatus (100) is configured to convert SIM- related request signals to file access signals which identify a location or locations on the user removable memory (40) and one or more file access functions. The file access signals are transferred to the user removable memory (40) via the connectors.
    Type: Application
    Filed: September 1, 2011
    Publication date: July 31, 2014
    Applicant: Nokia Corporation
    Inventors: Canfeng Chen, Changjiang Zhang, Jianying Wen, Xuan Guo, Xin Zhang
  • Publication number: 20140205619
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
    Type: Application
    Filed: January 13, 2014
    Publication date: July 24, 2014
    Applicants: BIOLEX THERAPEUTICS, INC., MERIAL LIMITED
    Inventors: Xuan Guo, Michel Bublot, Joyce Anita Pritchard, Lynn Dickey
  • Publication number: 20140205993
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
    Type: Application
    Filed: January 18, 2013
    Publication date: July 24, 2014
    Applicants: Biolex Therapeutics, Inc., Merial Limited
    Inventors: Xuan Guo, Michel Bublot, Joyce Anita Pritchard, Lynn Dickey
  • Patent number: 8394384
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: March 12, 2013
    Assignees: Merial Limited, Biolex Therapeutics, Inc.
    Inventors: Xuan Guo, Michel Bublot, Joyce A. Pritchard, Lynn F. Dickey
  • Publication number: 20110236420
    Abstract: The present invention encompasses BTV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing BTV antigens. The invention also encompasses recombinant vectors encoding and expressing BTV antigens, epitopes or immunogens which can be used to protect animals, such as ovines, bovines, or caprines, against BTV.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 29, 2011
    Inventors: Jean-Christophe Audonnet, Xuan Guo, Kevin Cox
  • Publication number: 20110236416
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or porcines, against FMDV.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 29, 2011
    Inventors: Jean-Christophe Audonnet, Xuan Guo, Bradley J. Feilmeir, Karolyn Marie Troupe, Michel Bublot, Kevin Cox
  • Publication number: 20110195480
    Abstract: The present invention is directed to recombinant microalgal cells and their use in production of heterologous hemagglutinin-neuraminidase (HN) polypeptides, as well as compositions and uses thereof.
    Type: Application
    Filed: December 28, 2010
    Publication date: August 11, 2011
    Inventors: Anne-Cécile V. Bayne, James Casey Lippmeier, Kirk Emil APT, Xuan Guo, Joyce A. Pritchard
  • Publication number: 20110162115
    Abstract: The present invention encompasses NDV vaccines. The vaccine may be a subunit vaccine based on HN of NDV. The NDV HN may be expressed in plants or algae including microalgae. The invention also encompasses recombinant vectors encoding and expressing NDV antigens, epitopes or immunogens which can be used to protect animals against NDV. It encompasses also a vaccination regime compatible with the DIVA strategy, including a prime-boost scheme using viral vector or inactivated vaccines and subunit vaccines.
    Type: Application
    Filed: December 28, 2010
    Publication date: June 30, 2011
    Inventors: Xuan Guo, Karolyn Marie Troupe, Bradley J. Feilmeier, Joyee A. Pritchard, Julio Sergio Cruz-Coy
  • Publication number: 20110009291
    Abstract: Methods and compositions for increasing membrane permeability are provided. One aspect provides protein resulting from a fusion between a membrane-active peptide and second peptide. Nucleic acids and vectors encoding the pore forming fusion proteins are also provided.
    Type: Application
    Filed: July 29, 2010
    Publication date: January 13, 2011
    Inventors: Rachel R. Chen, Xuan Guo
  • Publication number: 20100189731
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses recombinant vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals against influenza. It encompasses also a vaccination regimen compatible with the DIVA strategy, including a prime-boost scheme using vector and subunit vaccines.
    Type: Application
    Filed: November 30, 2009
    Publication date: July 29, 2010
    Inventors: Xuan GUO, Michel Bublot, Joyce A. Pritchard, Lynn F. Dickey
  • Publication number: 20080280781
    Abstract: Methods and compositions for increasing membrane permeability are provided. One aspect provides protein resulting from a fusion between a membrane-active peptide and second peptide. Nucleic acids, and vectors encoding the, pore forming fusion proteins are also provided.
    Type: Application
    Filed: January 17, 2006
    Publication date: November 13, 2008
    Inventors: Rachel R. Chen, Xuan Guo